UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results
5 January 2026
1 min read

UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

NEW YORK, Jan 4, 2026, 17:40 ET — Market closed

UnitedHealth Group (UNH) shares ended Friday up 1.9% at $336.40, closing out the first session of the year with a firm tone in managed care.

The move matters because investors are now lining up around the next big waypoint: UnitedHealth’s full-year results and 2026 outlook. The company said it will report before the market opens on Jan. 27 and host a conference call at 8 a.m. ET. 1

That guidance will be scrutinized for any sign that medical costs are easing, particularly in Medicare Advantage — privately run plans that manage traditional Medicare benefits — after a bruising stretch for the sector. Traders will also key in on the medical care ratio, which measures medical costs as a share of premiums; a higher ratio typically means tighter underwriting margins.

Health insurers broadly advanced on Friday, with Humana up 3.3% and Elevance Health up 1.1% in a session that also lifted the S&P 500. 2

UnitedHealth swung between $327.50 and $340.21 during the day and traded roughly 6.9 million shares, in line with its recent daily volumes.

The stock remains volatile on a longer lens. It is still far below its 52-week high of $606.36, with the past-year range running from $234.60 to $606.36, leaving clear technical reference points for traders heading into Monday.

MarketBeat data put the shares above both their 50-day and 200-day moving averages — commonly watched trend lines that smooth out day-to-day swings — while pegging the company’s market value at roughly $305 billion. 3

On expectations, MarketBeat’s earnings page lists consensus adjusted earnings per share — profit that strips out certain one-off items — at $2.09 for the Jan. 27 report, with expected revenue of about $113.38 billion.

But the path into earnings still runs through policy and compliance risk. UnitedHealth said it would make operational changes after outside audits of parts of its health services and pharmacy-benefit businesses, and it is cooperating with Justice Department investigations into billing practices; CEO Stephen Hemsley wrote that “the work is already well underway.” 4

For the broader tape, investors will also watch this week’s U.S. data — including the monthly jobs report due Jan. 9 — for clues on interest-rate expectations that can shift leadership between defensive names like insurers and higher-growth parts of the market. 5

The next company-specific catalyst is Jan. 27, when UnitedHealth reports results and sets out its 2026 targets — a read-through moment not just for UNH, but for the wider managed-care group.

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
CoreWeave stock (CRWV) in focus after SEC filing eases liquidity and covenant tests
Previous Story

CoreWeave stock (CRWV) in focus after SEC filing eases liquidity and covenant tests

Mastercard stock slides into 2026 after four-day skid; jobs report and earnings date loom
Next Story

Mastercard stock slides into 2026 after four-day skid; jobs report and earnings date loom

Go toTop